US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kalvista Pharmaceuticals Inc

15.84

+0.61004.01%

Pre-market: 16.100.2600+1.64%05:31 EST

Volume:594.38K

Turnover:9.44M

Market Cap:800.65M

PE:-4.01

High:16.13

Open:15.32

Low:15.13

Close:15.23

52wk High:17.30

52wk Low:7.30

Shares:50.55M

Float Shares:27.81M

Volume Ratio:0.47

T/O Rate:2.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.9460

EPS(LYR):-3.6945

ROE:-190.18%

ROA:-60.98%

PB:19.63

PE(LYR):-4.29

Loading ...

Overview Company News Filings

KalVista Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Operations Officer Arif Bilal

KalVista Pharmaceuticals Announces Positive Clinical Data and European Launch of EKTERLY®, the First Oral On-Demand Treatment for Hereditary Angioedema

KalVista Pharmaceuticals Appoints Bilal Arif as COO and Linea Aspesi as Chief People Officer Amid Global EKTERLY Launch

Kalvista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer

THOMSON REUTERS

KalVista Pharmaceuticals Grants Stock Options to New Employees Under Inducement Equity Incentive Plan

KalVista Pharmaceuticals Appoints Bethany L. Sensenig to Board of Directors and Audit Committee

Kalvista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors

THOMSON REUTERS

H.C. Wainwright Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)

KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, with Option for Additional $15 Million

KalVista Pharmaceuticals Announces New Clinical Data on EKTERLY® (Sebetralstat) for Hereditary Angioedema at German Allergy Congress

Kalvista Prices Upsized Offering of $125.0 Million of 3.250% Convertible Senior Notes Due 2031

THOMSON REUTERS

BUZZ-KalVista Pharma falls after announcing $110 mln convertible debt offering

KalVista announces $110M convertible senior notes offering

KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, With Option for Additional $15 Million

Kalvista Pharmaceuticals Inc - Proceeds to Fund Working Capital and Ekterly Commercialization

THOMSON REUTERS

Kalvista Pharmaceuticals Inc - Notes Mature on October 1, 2031

THOMSON REUTERS

Kalvista Pharmaceuticals Announces Proposed Offering of $110.0 Million of Convertible Senior Notes

THOMSON REUTERS

Sector Update: Health Care Stocks Rise Pre-Bell Friday

MT Newswires Live

KalVista Gets European Commission, Swissmedic Approvals for Ekterly to Treat Hereditary Angioedema

MT Newswires Live

Kalvista Pharmaceuticals Inc - First European Launch of Ekterly Expected in Germany Q4 2025

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KALV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KALV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KALV\",,,,,undefined,":{"symbol":"KALV","market":"US","secType":"STK","nameCN":"Kalvista Pharmaceuticals Inc","latestPrice":15.84,"timestamp":1766437200000,"preClose":15.23,"halted":0,"volume":594376,"hourTrading":{"tag":"盘前","latestPrice":16.1,"preClose":15.84,"latestTime":"05:31 EST","volume":550,"amount":8731.4601,"timestamp":1766485907648},"delay":0,"floatShares":27812263,"shares":50546293,"eps":-3.946012,"marketStatus":"Pre-Mkt","change":0.61,"latestTime":"12-23 05:45:07 EST","open":15.32,"high":16.13,"low":15.13,"amount":9441857.715328,"amplitude":0.06566,"askPrice":21.81,"askSize":100,"bidPrice":9.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.946012,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766500200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1479790800000,"exchange":"NASDAQ","adjPreClose":15.84,"preHourTrading":{"tag":"盘前","latestPrice":16.1,"preClose":15.84,"latestTime":"05:31 EST","volume":550,"amount":8731.4601,"timestamp":1766485907648},"postHourTrading":{"tag":"盘后","latestPrice":15.84,"preClose":15.84,"latestTime":"18:44 EST","volume":15760,"amount":249636.28,"timestamp":1766447092039},"volumeRatio":0.47046144284572916,"impliedVol":0.4871,"impliedVolPercentile":0.1486},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KALV\",,,,,undefined,":{"symbol":"KALV","floatShares":27812263,"roa":"-60.98%","roe":"-190.18%","lyrEps":-3.694529,"volumeRatio":0.47046144284572916,"shares":50546293,"dividePrice":0,"high":16.13,"amplitude":0.06566,"preClose":15.23,"low":15.13,"week52Low":7.3,"pbRate":"19.63","psRate":"561.47","week52High":17.3,"institutionHeld":0,"latestPrice":15.84,"eps":-3.946012,"divideRate":0,"volume":594376,"delay":0,"ttmEps":-3.946012,"open":15.32,"prevYearClose":8.47,"prevWeekClose":15.23,"prevMonthClose":14.47,"prevQuarterClose":12.18,"fiveDayClose":16.9,"twentyDayClose":13.1,"sixtyDayClose":12.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KALV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"KALV","fiscalQuarterEnding":"2025/09","expectedEps":-0.96,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.92},{"market":"US","date":"2025-09-11","symbol":"KALV","fiscalQuarterEnding":"2025/07","expectedEps":-0.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1757563200000,"reportTimeType":"pre","actualEps":-1.12},{"market":"US","date":"2025-07-10","symbol":"KALV","fiscalQuarterEnding":"2025/04","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1752120000000,"reportTimeType":"pre","actualEps":-0.99},{"market":"US","date":"2025-03-12","symbol":"KALV","fiscalQuarterEnding":"2025/01","expectedEps":-0.89,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"pre","actualEps":-0.92},{"market":"US","date":"2024-12-05","symbol":"KALV","fiscalQuarterEnding":"2024/10","expectedEps":-0.92,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1733374800000,"reportTimeType":"pre","actualEps":-0.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KALV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KALV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.5556,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1738558800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KALV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KALV","date":"2025-12-19","current":-4.014179,"percent":0.541233,"low":-26.712933,"twenty":-6.385563,"median":-3.910611,"eighty":-3.035234,"high":-1.157457,"avg":-5.48498,"sd":4.345408,"marketCap":758194395},"quantilePoints":[{"date":"2020-12-24","current":-8.469306,"twenty":-21.232957,"median":-9.507547,"eighty":-5.550337,"marketCap":314346748},{"date":"2020-12-31","current":-9.179915,"twenty":-21.044795,"median":-9.483591,"eighty":-5.562231,"marketCap":340721732},{"date":"2021-01-08","current":-8.043907,"twenty":-20.978555,"median":-9.467896,"eighty":-5.567258,"marketCap":298557642},{"date":"2021-01-15","current":-8.406463,"twenty":-20.947835,"median":-9.448647,"eighty":-5.576974,"marketCap":312014266},{"date":"2021-01-22","current":-7.797369,"twenty":-20.938867,"median":-9.422699,"eighty":-5.602707,"marketCap":289407137},{"date":"2021-01-29","current":-7.347799,"twenty":-20.726504,"median":-9.405114,"eighty":-5.628372,"marketCap":272720923},{"date":"2021-02-05","current":-7.352633,"twenty":-20.546505,"median":-9.373611,"eighty":-5.646403,"marketCap":272900344},{"date":"2021-02-12","current":-26.712933,"twenty":-20.726504,"median":-9.392928,"eighty":-5.654228,"marketCap":991477223},{"date":"2021-02-19","current":-24.554312,"twenty":-20.988155,"median":-9.414413,"eighty":-5.67951,"marketCap":911357851},{"date":"2021-02-26","current":-20.626124,"twenty":-21.258877,"median":-9.440089,"eighty":-5.72406,"marketCap":765559228},{"date":"2021-03-05","current":-19.377387,"twenty":-21.138876,"median":-9.458721,"eighty":-5.739303,"marketCap":719211103},{"date":"2021-03-12","current":-20.860166,"twenty":-20.989664,"median":-9.482882,"eighty":-5.748647,"marketCap":790016207},{"date":"2021-03-19","current":-20.783144,"twenty":-21.258877,"median":-9.503773,"eighty":-5.76543,"marketCap":787099224},{"date":"2021-03-26","current":-17.971835,"twenty":-21.214778,"median":-9.540006,"eighty":-5.797608,"marketCap":680629348},{"date":"2021-04-01","current":-17.625236,"twenty":-21.149559,"median":-9.55135,"eighty":-5.814845,"marketCap":667502924},{"date":"2021-04-09","current":-16.78441,"twenty":-20.99371,"median":-9.556921,"eighty":-5.818293,"marketCap":635659194},{"date":"2021-04-16","current":-15.693263,"twenty":-20.976773,"median":-9.61126,"eighty":-5.832083,"marketCap":594335269},{"date":"2021-04-23","current":-15.7061,"twenty":-20.967275,"median":-9.612147,"eighty":-5.83668,"marketCap":594821433},{"date":"2021-04-30","current":-16.027026,"twenty":-20.940526,"median":-9.678093,"eighty":-5.856215,"marketCap":606975529},{"date":"2021-05-07","current":-16.187489,"twenty":-20.9218,"median":-9.704874,"eighty":-5.863141,"marketCap":613052577},{"date":"2021-05-14","current":-16.726644,"twenty":-20.857283,"median":-9.745168,"eighty":-5.877022,"marketCap":633471457},{"date":"2021-05-21","current":-16.811935,"twenty":-20.83323,"median":-9.785618,"eighty":-5.896668,"marketCap":636701587},{"date":"2021-05-28","current":-17.41167,"twenty":-20.75174,"median":-9.79099,"eighty":-5.90442,"marketCap":659414763},{"date":"2021-06-04","current":-17.04409,"twenty":-20.626124,"median":-9.799069,"eighty":-5.913345,"marketCap":645493784},{"date":"2021-06-11","current":-18.533755,"twenty":-20.586034,"median":-9.811455,"eighty":-5.918271,"marketCap":701910381},{"date":"2021-06-18","current":-18.075893,"twenty":-20.520152,"median":-9.843589,"eighty":-5.941255,"marketCap":684570215},{"date":"2021-06-25","current":-18.030752,"twenty":-20.513378,"median":-9.870785,"eighty":-5.97573,"marketCap":682860621},{"date":"2021-07-02","current":-15.115909,"twenty":-20.487751,"median":-9.886663,"eighty":-5.97573,"marketCap":572469705},{"date":"2021-07-09","current":-14.806368,"twenty":-20.470471,"median":-9.906604,"eighty":-5.980327,"marketCap":560746776},{"date":"2021-07-16","current":-11.577795,"twenty":-20.442465,"median":-9.931245,"eighty":-6.013653,"marketCap":535403539},{"date":"2021-07-23","current":-11.239603,"twenty":-20.41703,"median":-9.935195,"eighty":-6.024733,"marketCap":519764184},{"date":"2021-07-30","current":-10.642482,"twenty":-20.36895,"median":-10.02465,"eighty":-6.037857,"marketCap":492150948},{"date":"2021-08-06","current":-10.526229,"twenty":-20.35815,"median":-10.080791,"eighty":-6.080593,"marketCap":486774920},{"date":"2021-08-13","current":-10.203889,"twenty":-20.33223,"median":-10.138374,"eighty":-6.114291,"marketCap":471868660},{"date":"2021-08-20","current":-9.728714,"twenty":-20.32575,"median":-10.088058,"eighty":-6.156324,"marketCap":449894651},{"date":"2021-08-27","current":-11.134384,"twenty":-20.299987,"median":-10.138374,"eighty":-6.165345,"marketCap":514898441},{"date":"2021-09-03","current":-10.706341,"twenty":-20.267469,"median":-10.155617,"eighty":-6.18096,"marketCap":495104053},{"date":"2021-09-10","current":-9.578084,"twenty":-20.245297,"median":-10.155617,"eighty":-6.21797,"marketCap":493644893},{"date":"2021-09-17","current":-9.12763,"twenty":-20.213596,"median":-10.138374,"eighty":-6.250384,"marketCap":470428920},{"date":"2021-09-24","current":-8.795716,"twenty":-20.155294,"median":-10.088058,"eighty":-6.257279,"marketCap":453322414},{"date":"2021-10-01","current":-8.217238,"twenty":-20.10972,"median":-10.041851,"eighty":-6.264174,"marketCap":423508217},{"date":"2021-10-08","current":-8.250429,"twenty":-20.053588,"median":-10.013512,"eighty":-6.268771,"marketCap":425218868},{"date":"2021-10-15","current":-8.160338,"twenty":-20.004942,"median":-9.935195,"eighty":-6.268771,"marketCap":420575673},{"date":"2021-10-22","current":-7.965932,"twenty":-19.978678,"median":-9.928498,"eighty":-6.275666,"marketCap":410556148},{"date":"2021-10-29","current":-8.525443,"twenty":-19.922322,"median":-9.903412,"eighty":-6.280263,"marketCap":439392830},{"date":"2021-11-05","current":-8.610793,"twenty":-19.879677,"median":-9.877142,"eighty":-6.281869,"marketCap":443791646},{"date":"2021-11-12","current":-8.378453,"twenty":-19.831313,"median":-9.856541,"eighty":-6.336494,"marketCap":431817092},{"date":"2021-11-19","current":-7.875841,"twenty":-19.770206,"median":-9.839276,"eighty":-6.372197,"marketCap":405912954},{"date":"2021-11-26","current":-7.150372,"twenty":-19.735066,"median":-9.812511,"eighty":-6.376794,"marketCap":368523019},{"date":"2021-12-03","current":-5.86065,"twenty":-19.683562,"median":-9.803588,"eighty":-6.374313,"marketCap":302052023},{"date":"2021-12-10","current":-5.440776,"twenty":-19.629284,"median":-9.79099,"eighty":-6.281333,"marketCap":330587011},{"date":"2021-12-17","current":-5.315932,"twenty":-19.592093,"median":-9.785618,"eighty":-6.268771,"marketCap":323001373},{"date":"2021-12-23","current":-5.815308,"twenty":-19.526544,"median":-9.758677,"eighty":-6.25482,"marketCap":353343926},{"date":"2021-12-31","current":-5.328014,"twenty":-19.427593,"median":-9.73108,"eighty":-6.165345,"marketCap":323735467},{"date":"2022-01-07","current":-5.231361,"twenty":-19.359562,"median":-9.678449,"eighty":-6.028583,"marketCap":317862714},{"date":"2022-01-14","current":-5.050136,"twenty":-19.275966,"median":-9.669428,"eighty":-5.97573,"marketCap":306851304},{"date":"2022-01-21","current":-4.675604,"twenty":-19.226786,"median":-9.61126,"eighty":-5.917549,"marketCap":284094389},{"date":"2022-01-28","current":-4.719904,"twenty":-19.038973,"median":-9.602702,"eighty":-5.872455,"marketCap":286786067},{"date":"2022-02-04","current":-5.311905,"twenty":-18.920681,"median":-9.559118,"eighty":-5.832083,"marketCap":322756675},{"date":"2022-02-11","current":-6.064996,"twenty":-18.894886,"median":-9.554037,"eighty":-5.832083,"marketCap":368515203},{"date":"2022-02-18","current":-6.26233,"twenty":-18.813739,"median":-9.549042,"eighty":-5.832083,"marketCap":380505405},{"date":"2022-02-25","current":-6.471745,"twenty":-18.753258,"median":-9.540006,"eighty":-5.850469,"marketCap":393229702},{"date":"2022-03-04","current":-6.330792,"twenty":-18.736138,"median":-9.503773,"eighty":-5.859533,"marketCap":384665271},{"date":"2022-03-11","current":-5.161388,"twenty":-18.734061,"median":-9.482882,"eighty":-5.850469,"marketCap":377720709},{"date":"2022-03-18","current":-5.245231,"twenty":-18.656282,"median":-9.460337,"eighty":-5.814845,"marketCap":383856523},{"date":"2022-03-25","current":-5.372673,"twenty":-18.605577,"median":-9.448647,"eighty":-5.750642,"marketCap":393182961},{"date":"2022-04-01","current":-5.030593,"twenty":-18.569418,"median":-9.418556,"eighty":-5.678382,"marketCap":368148840},{"date":"2022-04-08","current":-4.758941,"twenty":-18.547457,"median":-9.395816,"eighty":-5.640723,"marketCap":348268802},{"date":"2022-04-14","current":-4.815954,"twenty":-18.537748,"median":-9.373611,"eighty":-5.601865,"marketCap":352441156},{"date":"2022-04-22","current":-4.564425,"twenty":-18.461984,"median":-9.338328,"eighty":-5.560538,"marketCap":334033714},{"date":"2022-04-29","current":-4.269296,"twenty":-18.405112,"median":-9.313117,"eighty":-5.535966,"marketCap":312435648},{"date":"2022-05-06","current":-3.809836,"twenty":-18.394768,"median":-9.281755,"eighty":-5.492046,"marketCap":278811388},{"date":"2022-05-13","current":-3.25647,"twenty":-18.327474,"median":-9.263667,"eighty":-5.467356,"marketCap":238315015},{"date":"2022-05-20","current":-3.025063,"twenty":-18.279297,"median":-9.242266,"eighty":-5.434907,"marketCap":221380169},{"date":"2022-05-27","current":-3.011648,"twenty":-18.229202,"median":-9.214148,"eighty":-5.406406,"marketCap":220398438},{"date":"2022-06-03","current":-3.018356,"twenty":-18.162264,"median":-9.191891,"eighty":-5.383999,"marketCap":220889304},{"date":"2022-06-10","current":-2.800363,"twenty":-18.10833,"median":-9.167406,"eighty":-5.36913,"marketCap":204936187},{"date":"2022-06-17","current":-3.0586,"twenty":-18.095239,"median":-9.157656,"eighty":-5.356176,"marketCap":223834494},{"date":"2022-06-24","current":-3.464402,"twenty":-18.072024,"median":-9.140421,"eighty":-5.344467,"marketCap":253531834},{"date":"2022-07-01","current":-3.320191,"twenty":-18.052442,"median":-9.131967,"eighty":-5.332091,"marketCap":242978234},{"date":"2022-07-08","current":-3.303411,"twenty":-18.03602,"median":-9.129602,"eighty":-5.315932,"marketCap":271999553},{"date":"2022-07-15","current":-3.679409,"twenty":-18.030752,"median":-9.12698,"eighty":-5.299824,"marketCap":302958851},{"date":"2022-07-22","current":-4.013629,"twenty":-17.971835,"median":-9.097738,"eighty":-5.27566,"marketCap":330478228},{"date":"2022-07-29","current":-3.685377,"twenty":-17.837971,"median":-9.072071,"eighty":-5.232449,"marketCap":303450269},{"date":"2022-08-05","current":-4.106137,"twenty":-17.837971,"median":-9.006003,"eighty":-5.206415,"marketCap":338095198},{"date":"2022-08-12","current":-4.422453,"twenty":-17.837971,"median":-8.885027,"eighty":-5.187177,"marketCap":364140323},{"date":"2022-08-19","current":-4.479151,"twenty":-17.837971,"median":-8.802132,"eighty":-5.165186,"marketCap":368808788},{"date":"2022-08-26","current":-4.855149,"twenty":-17.837971,"median":-8.802132,"eighty":-5.148547,"marketCap":399768087},{"date":"2022-09-02","current":-4.816355,"twenty":-17.837971,"median":-8.754215,"eighty":-5.136538,"marketCap":396573874},{"date":"2022-09-09","current":-4.373534,"twenty":-17.837971,"median":-8.667692,"eighty":-5.127353,"marketCap":390434105},{"date":"2022-09-16","current":-4.131019,"twenty":-17.837971,"median":-8.653467,"eighty":-5.107209,"marketCap":368784324},{"date":"2022-09-23","current":-3.654257,"twenty":-17.837971,"median":-8.653467,"eighty":-5.104328,"marketCap":326222824},{"date":"2022-09-30","current":-3.998738,"twenty":-17.837971,"median":-8.653467,"eighty":-5.102379,"marketCap":356975353},{"date":"2022-10-07","current":-1.364146,"twenty":-17.837971,"median":-8.653467,"eighty":-5.092671,"marketCap":121780013},{"date":"2022-10-14","current":-1.256668,"twenty":-17.837971,"median":-8.653467,"eighty":-5.077139,"marketCap":112185224},{"date":"2022-10-21","current":-1.207062,"twenty":-17.837971,"median":-8.639242,"eighty":-5.053179,"marketCap":107756860},{"date":"2022-10-28","current":-1.408239,"twenty":-17.837971,"median":-8.551485,"eighty":-5.032505,"marketCap":125716337},{"date":"2022-11-04","current":-1.438554,"twenty":-17.837971,"median":-8.509961,"eighty":-5.025059,"marketCap":128422560},{"date":"2022-11-11","current":-1.515717,"twenty":-17.837971,"median":-8.469306,"eighty":-5.015017,"marketCap":135311126},{"date":"2022-11-18","current":-1.402728,"twenty":-17.837971,"median":-8.406531,"eighty":-4.990348,"marketCap":125224297},{"date":"2022-11-25","current":-1.430286,"twenty":-17.837971,"median":-8.383195,"eighty":-4.979261,"marketCap":127684499},{"date":"2022-12-02","current":-1.482647,"twenty":-17.837971,"median":-8.383195,"eighty":-4.97089,"marketCap":132358883},{"date":"2022-12-09","current":-1.532606,"twenty":-17.837971,"median":-8.383195,"eighty":-4.958632,"marketCap":140815818},{"date":"2022-12-16","current":-1.508491,"twenty":-17.837971,"median":-8.383195,"eighty":-4.945952,"marketCap":138600184},{"date":"2022-12-23","current":-1.369164,"twenty":-17.837971,"median":-8.383195,"eighty":-4.937657,"marketCap":125798746},{"date":"2022-12-30","current":-2.509054,"twenty":-17.837971,"median":-8.383195,"eighty":-4.919678,"marketCap":230531865},{"date":"2023-01-06","current":-2.471938,"twenty":-17.837971,"median":-8.383195,"eighty":-4.911339,"marketCap":227121631},{"date":"2023-01-13","current":-2.635249,"twenty":-17.837971,"median":-8.383195,"eighty":-4.865413,"marketCap":242126663},{"date":"2023-01-20","current":-2.761444,"twenty":-17.837971,"median":-8.383195,"eighty":-4.846147,"marketCap":253721461},{"date":"2023-01-27","current":-3.017546,"twenty":-17.837971,"median":-8.383195,"eighty":-4.818838,"marketCap":277252081},{"date":"2023-02-03","current":-2.921043,"twenty":-17.837971,"median":-8.383195,"eighty":-4.787017,"marketCap":268385470},{"date":"2023-02-10","current":-2.954448,"twenty":-17.837971,"median":-8.383195,"eighty":-4.759049,"marketCap":271454682},{"date":"2023-02-17","current":-3.013834,"twenty":-17.837971,"median":-8.383195,"eighty":-4.738746,"marketCap":276911057},{"date":"2023-02-24","current":-2.783714,"twenty":-17.837971,"median":-8.383195,"eighty":-4.719904,"marketCap":255767602},{"date":"2023-03-03","current":-3.032392,"twenty":-17.837971,"median":-8.383195,"eighty":-4.706024,"marketCap":278616174},{"date":"2023-03-10","current":-2.621609,"twenty":-17.837971,"median":-8.383195,"eighty":-4.665707,"marketCap":237819288},{"date":"2023-03-17","current":-2.783577,"twenty":-17.837971,"median":-8.383195,"eighty":-4.630686,"marketCap":252512146},{"date":"2023-03-24","current":-2.452109,"twenty":-17.837971,"median":-8.383195,"eighty":-4.578352,"marketCap":222443041},{"date":"2023-03-31","current":-2.960611,"twenty":-17.79335,"median":-8.380824,"eighty":-4.538256,"marketCap":268571782},{"date":"2023-04-06","current":-2.911644,"twenty":-17.79335,"median":-8.380824,"eighty":-4.528094,"marketCap":264129755},{"date":"2023-04-14","current":-3.066078,"twenty":-17.837971,"median":-8.383195,"eighty":-4.486449,"marketCap":278139225},{"date":"2023-04-21","current":-3.073611,"twenty":-17.837971,"median":-8.383195,"eighty":-4.430028,"marketCap":278822614},{"date":"2023-04-28","current":-3.148945,"twenty":-17.837971,"median":-8.383195,"eighty":-4.400655,"marketCap":285656501},{"date":"2023-05-05","current":-3.518079,"twenty":-17.837971,"median":-8.383195,"eighty":-4.363613,"marketCap":319142550},{"date":"2023-05-12","current":-3.66498,"twenty":-17.837971,"median":-8.383195,"eighty":-4.321917,"marketCap":332468631},{"date":"2023-05-19","current":-3.917347,"twenty":-17.837971,"median":-8.383195,"eighty":-4.262531,"marketCap":355362155},{"date":"2023-05-26","current":-3.67628,"twenty":-17.837971,"median":-8.383195,"eighty":-4.171033,"marketCap":333493714},{"date":"2023-06-02","current":-3.796813,"twenty":-17.837971,"median":-8.383195,"eighty":-4.121066,"marketCap":344427935},{"date":"2023-06-09","current":-3.762913,"twenty":-17.837971,"median":-8.383195,"eighty":-4.074132,"marketCap":341352685},{"date":"2023-06-16","current":-3.627313,"twenty":-17.837971,"median":-8.383195,"eighty":-4.015419,"marketCap":329051687},{"date":"2023-06-23","current":-3.74408,"twenty":-17.882593,"median":-8.385161,"eighty":-3.981381,"marketCap":339644213},{"date":"2023-06-30","current":-3.390012,"twenty":-17.927214,"median":-8.387126,"eighty":-3.936556,"marketCap":307524942},{"date":"2023-07-07","current":-3.371179,"twenty":-17.927214,"median":-8.387126,"eighty":-3.918102,"marketCap":305816470},{"date":"2023-07-14","current":-3.596288,"twenty":-17.927214,"median":-8.387126,"eighty":-3.881733,"marketCap":334120355},{"date":"2023-07-21","current":-3.555756,"twenty":-17.927214,"median":-8.387126,"eighty":-3.85357,"marketCap":330354654},{"date":"2023-07-28","current":-3.518909,"twenty":-17.927214,"median":-8.387126,"eighty":-3.806286,"marketCap":326931290},{"date":"2023-08-04","current":-4.078987,"twenty":-17.927214,"median":-8.383195,"eighty":-3.787773,"marketCap":378966428},{"date":"2023-08-11","current":-3.998083,"twenty":-17.927214,"median":-8.359487,"eighty":-3.787773,"marketCap":371449889},{"date":"2023-08-18","current":-4.031277,"twenty":-17.927214,"median":-8.304947,"eighty":-3.787773,"marketCap":374533883},{"date":"2023-08-25","current":-3.911409,"twenty":-17.927214,"median":-8.276306,"eighty":-3.787773,"marketCap":363397239},{"date":"2023-09-01","current":-4.001771,"twenty":-17.927214,"median":-8.250429,"eighty":-3.787773,"marketCap":371792555},{"date":"2023-09-08","current":-3.918109,"twenty":-17.612375,"median":-8.208265,"eighty":-3.787773,"marketCap":372933484},{"date":"2023-09-15","current":-3.603649,"twenty":-17.509147,"median":-8.131888,"eighty":-3.767896,"marketCap":343002476},{"date":"2023-09-22","current":-3.455454,"twenty":-17.302041,"median":-8.043907,"eighty":-3.739154,"marketCap":328897058},{"date":"2023-09-29","current":-3.491599,"twenty":-17.040221,"median":-8.003865,"eighty":-3.711696,"marketCap":332337404},{"date":"2023-10-06","current":-3.545817,"twenty":-16.78441,"median":-7.931827,"eighty":-3.68029,"marketCap":337497922},{"date":"2023-10-13","current":-3.318104,"twenty":-16.726644,"median":-7.865046,"eighty":-3.665109,"marketCap":315823744},{"date":"2023-10-20","current":-3.198825,"twenty":-16.484024,"median":-7.827443,"eighty":-3.643446,"marketCap":304470603},{"date":"2023-10-27","current":-2.909666,"twenty":-16.240274,"median":-7.800236,"eighty":-3.634846,"marketCap":276947836},{"date":"2023-11-03","current":-3.131957,"twenty":-16.139992,"median":-7.76349,"eighty":-3.619654,"marketCap":298105963},{"date":"2023-11-10","current":-2.833762,"twenty":-16.012905,"median":-7.693722,"eighty":-3.600705,"marketCap":269723110},{"date":"2023-11-17","current":-2.750628,"twenty":-15.893521,"median":-7.611776,"eighty":-3.579671,"marketCap":261810315},{"date":"2023-11-24","current":-2.945811,"twenty":-15.740872,"median":-7.585145,"eighty":-3.551016,"marketCap":280388182},{"date":"2023-12-01","current":-3.050631,"twenty":-15.367493,"median":-7.560499,"eighty":-3.53878,"marketCap":290365185},{"date":"2023-12-08","current":-3.082194,"twenty":-14.897334,"median":-7.527267,"eighty":-3.509271,"marketCap":309991619},{"date":"2023-12-15","current":-3.607919,"twenty":-14.808948,"median":-7.401044,"eighty":-3.490153,"marketCap":362866444},{"date":"2023-12-22","current":-3.8725,"twenty":-14.50411,"median":-7.357088,"eighty":-3.490153,"marketCap":389476650},{"date":"2023-12-29","current":-4.150825,"twenty":-14.108779,"median":-7.326046,"eighty":-3.488707,"marketCap":417469204},{"date":"2024-01-05","current":-4.030561,"twenty":-13.968443,"median":-7.294625,"eighty":-3.487262,"marketCap":405373656},{"date":"2024-01-12","current":-4.508181,"twenty":-13.685978,"median":-7.184004,"eighty":-3.487262,"marketCap":453410262},{"date":"2024-01-19","current":-4.281397,"twenty":-13.439469,"median":-7.118384,"eighty":-3.485816,"marketCap":430601514},{"date":"2024-01-26","current":-4.415406,"twenty":-13.314139,"median":-7.07687,"eighty":-3.487262,"marketCap":444079410},{"date":"2024-02-02","current":-5.408442,"twenty":-13.179889,"median":-7.005442,"eighty":-3.487262,"marketCap":543954079},{"date":"2024-02-09","current":-5.119809,"twenty":-12.983332,"median":-6.875358,"eighty":-3.487262,"marketCap":514924764},{"date":"2024-02-16","current":-5.071703,"twenty":-12.906354,"median":-6.785901,"eighty":-3.487262,"marketCap":510086544},{"date":"2024-02-23","current":-5.200236,"twenty":-12.550065,"median":-6.722697,"eighty":-3.487262,"marketCap":523013764},{"date":"2024-03-01","current":-5.642546,"twenty":-12.446128,"median":-6.628065,"eighty":-3.488707,"marketCap":567499036},{"date":"2024-03-08","current":-5.789293,"twenty":-12.214813,"median":-6.524463,"eighty":-3.488707,"marketCap":582258169},{"date":"2024-03-15","current":-4.84211,"twenty":-11.98198,"median":-6.473684,"eighty":-3.488707,"marketCap":524400519},{"date":"2024-03-22","current":-4.733036,"twenty":-11.754396,"median":-6.452984,"eighty":-3.488707,"marketCap":512587796},{"date":"2024-03-28","current":-4.312322,"twenty":-11.689964,"median":-6.424518,"eighty":-3.488707,"marketCap":467024436},{"date":"2024-04-05","current":-4.366859,"twenty":-11.578128,"median":-6.377487,"eighty":-3.487262,"marketCap":472930798},{"date":"2024-04-12","current":-4.713558,"twenty":-11.456327,"median":-6.282939,"eighty":-3.487262,"marketCap":510478381},{"date":"2024-04-19","current":-4.479828,"twenty":-11.332917,"median":-6.268771,"eighty":-3.487262,"marketCap":485165404},{"date":"2024-04-26","current":-4.086383,"twenty":-11.226921,"median":-6.257279,"eighty":-3.488707,"marketCap":442555225},{"date":"2024-05-03","current":-4.740827,"twenty":-11.166695,"median":-6.165345,"eighty":-3.488707,"marketCap":513431562},{"date":"2024-05-10","current":-4.709663,"twenty":-11.03278,"median":-6.075064,"eighty":-3.488707,"marketCap":510056498},{"date":"2024-05-17","current":-4.701872,"twenty":-10.939114,"median":-5.978603,"eighty":-3.488707,"marketCap":509212732},{"date":"2024-05-24","current":-4.398023,"twenty":-10.832897,"median":-5.927156,"eighty":-3.488707,"marketCap":476305861},{"date":"2024-05-31","current":-4.546052,"twenty":-10.777169,"median":-5.860731,"eighty":-3.488707,"marketCap":492337414},{"date":"2024-06-07","current":-4.549947,"twenty":-10.70117,"median":-5.823695,"eighty":-3.488707,"marketCap":492759297},{"date":"2024-06-14","current":-4.701872,"twenty":-10.638259,"median":-5.787705,"eighty":-3.488707,"marketCap":509212732},{"date":"2024-06-21","current":-4.57332,"twenty":-10.590761,"median":-5.734403,"eighty":-3.487262,"marketCap":495290595},{"date":"2024-06-28","current":-4.588902,"twenty":-10.545998,"median":-5.659081,"eighty":-3.487262,"marketCap":496978126},{"date":"2024-07-05","current":-4.592798,"twenty":-10.487182,"median":-5.601865,"eighty":-3.487262,"marketCap":497400009},{"date":"2024-07-12","current":-4.40031,"twenty":-10.410809,"median":-5.535069,"eighty":-3.487262,"marketCap":557272836},{"date":"2024-07-19","current":-4.909855,"twenty":-10.348643,"median":-5.493407,"eighty":-3.487262,"marketCap":621803663},{"date":"2024-07-26","current":-4.990842,"twenty":-10.271352,"median":-5.464346,"eighty":-3.487262,"marketCap":632060219},{"date":"2024-08-02","current":-4.444178,"twenty":-10.223016,"median":-5.409564,"eighty":-3.487262,"marketCap":562828470},{"date":"2024-08-09","current":-4.353067,"twenty":-10.163072,"median":-5.345843,"eighty":-3.487262,"marketCap":551289846},{"date":"2024-08-16","current":-4.049365,"twenty":-10.085151,"median":-5.315932,"eighty":-3.487262,"marketCap":512827764},{"date":"2024-08-23","current":-4.29649,"twenty":-10.011936,"median":-5.245231,"eighty":-3.487262,"marketCap":544124674},{"date":"2024-08-30","current":-4.555028,"twenty":-9.928269,"median":-5.200236,"eighty":-3.487262,"marketCap":576866935},{"date":"2024-09-06","current":-3.761578,"twenty":-9.858836,"median":-5.147973,"eighty":-3.487262,"marketCap":533278924},{"date":"2024-09-13","current":-3.395784,"twenty":-9.80126,"median":-5.103109,"eighty":-3.468426,"marketCap":481420358},{"date":"2024-09-20","current":-3.197646,"twenty":-9.730134,"median":-5.088884,"eighty":-3.451786,"marketCap":453330301},{"date":"2024-09-27","current":-3.761578,"twenty":-9.604413,"median":-5.050715,"eighty":-3.433767,"marketCap":533278924},{"date":"2024-10-04","current":-3.462847,"twenty":-9.550427,"median":-5.027239,"eighty":-3.433767,"marketCap":490927761},{"date":"2024-10-11","current":-3.54515,"twenty":-9.550427,"median":-4.981673,"eighty":-3.417997,"marketCap":502595939},{"date":"2024-10-18","current":-3.810351,"twenty":-9.545428,"median":-4.947656,"eighty":-3.417997,"marketCap":540193400},{"date":"2024-10-25","current":-3.560392,"twenty":-9.489729,"median":-4.917815,"eighty":-3.417997,"marketCap":504756712},{"date":"2024-11-01","current":-3.234226,"twenty":-9.457913,"median":-4.90648,"eighty":-3.408677,"marketCap":458516157},{"date":"2024-11-08","current":-3.960983,"twenty":-9.372815,"median":-4.865483,"eighty":-3.408677,"marketCap":561548535},{"date":"2024-11-15","current":-3.294455,"twenty":-9.298489,"median":-4.855149,"eighty":-3.403274,"marketCap":467054829},{"date":"2024-11-22","current":-3.523574,"twenty":-9.214148,"median":-4.816355,"eighty":-3.394581,"marketCap":499537040},{"date":"2024-11-29","current":-3.49233,"twenty":-9.137375,"median":-4.791748,"eighty":-3.394581,"marketCap":495107648},{"date":"2024-12-06","current":-3.099941,"twenty":-9.08314,"median":-4.7642,"eighty":-3.372248,"marketCap":484790442},{"date":"2024-12-13","current":-2.746023,"twenty":-8.871686,"median":-4.744722,"eighty":-3.350974,"marketCap":429442298},{"date":"2024-12-20","current":-2.641744,"twenty":-8.745815,"median":-4.72914,"eighty":-3.318939,"marketCap":413134362},{"date":"2024-12-27","current":-2.695463,"twenty":-8.664771,"median":-4.718696,"eighty":-3.301406,"marketCap":421535420},{"date":"2025-01-03","current":-2.853462,"twenty":-8.597516,"median":-4.709663,"eighty":-3.283415,"marketCap":446244413},{"date":"2025-01-10","current":-2.480585,"twenty":-8.54441,"median":-4.701872,"eighty":-3.267552,"marketCap":387931190},{"date":"2025-01-17","current":-2.622784,"twenty":-8.503884,"median":-4.677052,"eighty":-3.245933,"marketCap":410169283},{"date":"2025-01-24","current":-2.720743,"twenty":-8.466641,"median":-4.669262,"eighty":-3.229642,"marketCap":425488859},{"date":"2025-01-31","current":-2.815543,"twenty":-8.406517,"median":-4.647335,"eighty":-3.215033,"marketCap":440314255},{"date":"2025-02-07","current":-2.907182,"twenty":-8.377475,"median":-4.631753,"eighty":-3.191832,"marketCap":454645471},{"date":"2025-02-14","current":-3.084141,"twenty":-8.350549,"median":-4.619735,"eighty":-3.173524,"marketCap":482319543},{"date":"2025-02-21","current":-3.16946,"twenty":-8.304475,"median":-4.608379,"eighty":-3.162031,"marketCap":495662399},{"date":"2025-02-28","current":-3.600798,"twenty":-8.275872,"median":-4.589232,"eighty":-3.162031,"marketCap":563117950},{"date":"2025-03-07","current":-3.766697,"twenty":-8.245688,"median":-4.564425,"eighty":-3.160174,"marketCap":589062393},{"date":"2025-03-14","current":-3.561879,"twenty":-8.217238,"median":-4.553843,"eighty":-3.160174,"marketCap":626417013},{"date":"2025-03-21","current":-3.36117,"twenty":-8.217238,"median":-4.553843,"eighty":-3.160174,"marketCap":591118912},{"date":"2025-03-28","current":-3.372478,"twenty":-8.217238,"median":-4.553843,"eighty":-3.160174,"marketCap":593107537},{"date":"2025-04-04","current":-3.027597,"twenty":-8.217238,"median":-4.553843,"eighty":-3.141709,"marketCap":532454461},{"date":"2025-04-11","current":-3.248095,"twenty":-8.216635,"median":-4.542442,"eighty":-3.132319,"marketCap":571232657},{"date":"2025-04-17","current":-3.392266,"twenty":-8.216635,"median":-4.518399,"eighty":-3.132319,"marketCap":596587632},{"date":"2025-04-25","current":-3.672128,"twenty":-8.217238,"median":-4.483724,"eighty":-3.131957,"marketCap":645806111},{"date":"2025-05-02","current":-3.830434,"twenty":-8.217238,"median":-4.463511,"eighty":-3.131957,"marketCap":673646867},{"date":"2025-05-09","current":-3.363997,"twenty":-8.217238,"median":-4.440873,"eighty":-3.131957,"marketCap":591616068},{"date":"2025-05-16","current":-3.372478,"twenty":-8.217238,"median":-4.415406,"eighty":-3.131957,"marketCap":593107537},{"date":"2025-05-23","current":-3.228306,"twenty":-8.217238,"median":-4.40031,"eighty":-3.131957,"marketCap":567752563},{"date":"2025-05-30","current":-3.36117,"twenty":-8.217238,"median":-4.386336,"eighty":-3.131957,"marketCap":591118912},{"date":"2025-06-06","current":-3.901106,"twenty":-8.217238,"median":-4.373534,"eighty":-3.131957,"marketCap":686075776},{"date":"2025-06-13","current":-3.700397,"twenty":-8.217238,"median":-4.366859,"eighty":-3.131957,"marketCap":650777675},{"date":"2025-06-20","current":-3.479899,"twenty":-8.222928,"median":-4.3318,"eighty":-3.131682,"marketCap":611999479},{"date":"2025-06-27","current":-3.250922,"twenty":-8.222928,"median":-4.314723,"eighty":-3.131682,"marketCap":571729814},{"date":"2025-07-03","current":-3.386612,"twenty":-8.222928,"median":-4.300635,"eighty":-3.131682,"marketCap":595593319},{"date":"2025-07-11","current":-4.20733,"twenty":-8.222928,"median":-4.287148,"eighty":-3.131682,"marketCap":771809364},{"date":"2025-07-18","current":-4.342962,"twenty":-8.222928,"median":-4.27265,"eighty":-3.131682,"marketCap":796690388},{"date":"2025-07-25","current":-4.231743,"twenty":-8.222928,"median":-4.248806,"eighty":-3.131682,"marketCap":776287948},{"date":"2025-08-01","current":-3.69735,"twenty":-8.222928,"median":-4.224101,"eighty":-3.131682,"marketCap":678256714},{"date":"2025-08-08","current":-3.434223,"twenty":-8.222928,"median":-4.216401,"eighty":-3.131682,"marketCap":629987527},{"date":"2025-08-15","current":-3.51289,"twenty":-8.222928,"median":-4.192768,"eighty":-3.131682,"marketCap":644418521},{"date":"2025-08-22","current":-3.529145,"twenty":-8.204398,"median":-4.170246,"eighty":-3.131682,"marketCap":647400457},{"date":"2025-08-29","current":-3.707349,"twenty":-8.168957,"median":-4.130686,"eighty":-3.131682,"marketCap":680091008},{"date":"2025-09-05","current":-4.171111,"twenty":-8.177575,"median":-4.106137,"eighty":-3.131408,"marketCap":765165309},{"date":"2025-09-12","current":-3.684199,"twenty":-8.116715,"median":-4.106137,"eighty":-3.131682,"marketCap":748249687},{"date":"2025-09-19","current":-3.452848,"twenty":-8.116715,"median":-4.078822,"eighty":-3.131682,"marketCap":701263043},{"date":"2025-09-26","current":-3.008804,"twenty":-8.116715,"median":-4.061095,"eighty":-3.130143,"marketCap":611078999},{"date":"2025-10-03","current":-2.92298,"twenty":-8.116715,"median":-4.047697,"eighty":-3.102006,"marketCap":593648469},{"date":"2025-10-10","current":-2.937906,"twenty":-8.116715,"median":-4.030919,"eighty":-3.090104,"marketCap":596679865},{"date":"2025-10-17","current":-2.746357,"twenty":-8.047278,"median":-4.012645,"eighty":-3.08457,"marketCap":557776944},{"date":"2025-10-24","current":-2.736407,"twenty":-7.935623,"median":-3.99841,"eighty":-3.073352,"marketCap":555756014},{"date":"2025-10-31","current":-2.728944,"twenty":-7.853444,"median":-3.981381,"eighty":-3.058674,"marketCap":554240315},{"date":"2025-11-07","current":-2.709043,"twenty":-7.725057,"median":-3.970212,"eighty":-3.042702,"marketCap":550198453},{"date":"2025-11-14","current":-3.257808,"twenty":-7.558621,"median":-3.949337,"eighty":-3.035234,"marketCap":661650975},{"date":"2025-11-21","current":-3.240386,"twenty":-7.343932,"median":-3.927885,"eighty":-3.035234,"marketCap":658112734},{"date":"2025-11-28","current":-3.601259,"twenty":-7.111083,"median":-3.922265,"eighty":-3.035234,"marketCap":731404859},{"date":"2025-12-05","current":-4.081593,"twenty":-6.578869,"median":-3.9153,"eighty":-3.035234,"marketCap":828959205},{"date":"2025-12-12","current":-4.206031,"twenty":-6.450633,"median":-3.9153,"eighty":-3.035234,"marketCap":854232351},{"date":"2025-12-19","current":-3.733164,"twenty":-6.385563,"median":-3.910611,"eighty":-3.035234,"marketCap":758194395}],"updateTime":1766477026876},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KALV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574905703","title":"KalVista Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Operations Officer Arif Bilal","url":"https://stock-news.laohu8.com/highlight/detail?id=2574905703","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574905703?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:59","pubTimestamp":1759964353,"startTime":"0","endTime":"0","summary":"Kalvista Pharmaceuticals Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Arif Bilal, Chief Operations Officer, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL1ZT3NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2573684988","title":"KalVista Pharmaceuticals Announces Positive Clinical Data and European Launch of EKTERLY®, the First Oral On-Demand Treatment for Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2573684988","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573684988?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:00","pubTimestamp":1759780818,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Announces Positive Clinical Data and European Launch of EKTERLY, the First Oral On-Demand Treatment for Hereditary Angioedema. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on October 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDLc1k6wY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2573624679","title":"KalVista Pharmaceuticals Appoints Bilal Arif as COO and Linea Aspesi as Chief People Officer Amid Global EKTERLY Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2573624679","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573624679?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748437,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has appointed Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025. The new appointments come as the company prepares for the global launch of EKTERLY, its therapy for hereditary angioedema. Arif brings over 25 years of biopharmaceutical operations experience, previously serving at Sarepta Therapeutics and Momenta Pharmaceuticals. Aspesi joins as KalVista expands its organizational and people strategies to support business growth.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on October 06, 2025, and is solely responsible for the information ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDLbsYtSc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703251.USD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU2129689605.HKD","LU2347655156.SGD","LU2592432038.USD","LU0466842654.USD","LU1032466523.USD","LU1894683264.USD","LU2129689431.USD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU2430703178.SGD","LU1066051225.USD","IE0009355771.USD","LU2602419157.SGD","LU0795875169.SGD","IE00BVYPNW00.USD","LU0098860793.USD","LU1032955483.USD","LU0203347892.USD","IE00B7SZLL34.SGD","IE00BN8TJ469.HKD","LU2129689514.USD","LU1732799900.SGD","KALV","BK4504","BK4592","JNJ","LU1778281490.HKD","LU1430594728.SGD","LU1162221912.USD","LU1585245621.USD","LU0122379950.USD","LU1935042991.SGD","BK4007","IE0002270589.USD","BK4568","IE00BDGV0183.EUR","LU2430703095.HKD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1280957306.USD","LU0640476718.USD","IE0034235303.USD","SRPT","IE00B3T34201.USD","LU1074936037.SGD","LU0203345920.USD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2573679636","title":"Kalvista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2573679636","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573679636?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA1Y1PHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2572501990","title":"KalVista Pharmaceuticals Grants Stock Options to New Employees Under Inducement Equity Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2572501990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572501990?lang=en_us&edition=fundamental","pubTime":"2025-10-03 19:00","pubTimestamp":1759489215,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has announced the granting of inducement stock options to two newly-hired employees. The options allow the purchase of a total of 30,000 shares of KalVista common stock, with the exercise price set at the closing price on the first day a closing price is reported after the grant date. One-fourth of the options will vest on the first anniversary of the vesting start date, with the remainder vesting in equal monthly installments over the following three years. Each option carries a 10-year term and is governed by KalVista's Inducement Equity Incentive Plan and a stock option agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL5YtClk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2572548519","title":"KalVista Pharmaceuticals Appoints Bethany L. Sensenig to Board of Directors and Audit Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2572548519","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572548519?lang=en_us&edition=fundamental","pubTime":"2025-10-02 19:00","pubTimestamp":1759402833,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has appointed Bethany L. Sensenig to its Board of Directors, effective October 1, 2025. Sensenig will also join the Audit Committee. Nancy Stuart will step down from the Audit Committee but will remain on the Board and join the Compensation Committee. Sensenig is currently CFO and Head of Operations at Radius Health, Inc. and has previously held leadership roles at 9 Meters Biopharma, Minovia Therapeutics, and Biogen Inc.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on October 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nNDL8fSt0w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4007","IE00B19Z9P08.USD","BK4585","IE00B19Z9Z06.USD","KALV","BK4533","BK4532","IE00B894F039.SGD","LU0234570918.USD","LU0889565916.HKD","NMTRQ","BK4139","BIIB","LU0109394709.USD","BK4588"],"gpt_icon":0},{"id":"2572519518","title":"Kalvista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2572519518","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572519518?lang=en_us&edition=fundamental","pubTime":"2025-10-02 19:00","pubTimestamp":1759402800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nTUAWQJG9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2572538448","title":"H.C. Wainwright Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572538448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572538448?lang=en_us&edition=fundamental","pubTime":"2025-10-01 18:36","pubTimestamp":1759314961,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on KalVista Pharmaceuticals today and set a price target of $27.00. The company’s share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-kalvista-pharmaceuticals-kalv-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-kalvista-pharmaceuticals-kalv-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KALV"],"gpt_icon":0},{"id":"2571350723","title":"KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, with Option for Additional $15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2571350723","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571350723?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:28","pubTimestamp":1759177703,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, with Option for Additional $15 Million. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL5rmhVF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2570076970","title":"KalVista Pharmaceuticals Announces New Clinical Data on EKTERLY® (Sebetralstat) for Hereditary Angioedema at German Allergy Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2570076970","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570076970?lang=en_us&edition=fundamental","pubTime":"2025-09-26 19:00","pubTimestamp":1758884436,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Announces New Clinical Data on EKTERLY  for Hereditary Angioedema at German Allergy Congress. KalVista Pharmaceuticals Inc. has announced the acceptance of six abstracts for ePoster presentation at the upcoming 20th German Allergy Congress, scheduled to take place in Düsseldorf, Germany, from October 2-4, 2025. The presentations will cover new data on EKTERLY , including its use for the on-demand treatment of hereditary angioedema  attacks, its impact on anxiety associated with HAE, and its effectiveness in patients already receiving berotralstat. The results from these studies will be presented at the congress, with further details and links to all presentations available on the KalVista website under Publications.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDL2ZcShV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2570056165","title":"Kalvista Prices Upsized Offering of $125.0 Million of 3.250% Convertible Senior Notes Due 2031","url":"https://stock-news.laohu8.com/highlight/detail?id=2570056165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570056165?lang=en_us&edition=fundamental","pubTime":"2025-09-25 10:52","pubTimestamp":1758768721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nTUA3B0JZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2570080051","title":"BUZZ-KalVista Pharma falls after announcing $110 mln convertible debt offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2570080051","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570080051?lang=en_us&edition=fundamental","pubTime":"2025-09-25 04:26","pubTimestamp":1758745560,"startTime":"0","endTime":"0","summary":"** Shares of KalVista Pharmaceuticals KALV.O down 10.3% post-market to $11.60 after planned capital raise news. ** Framingham, Massachusetts-based KALV announces private offering of $110 mln 6-yr convertible bonds . ** Co intends to use net offering proceeds for working capital and other purposes, including commercialization of its drug, Ekterly** It also may use a portion of proceeds for future investments in and acquisitions of other firms, products or technologies** Last week, KALV said European Commission and Swiss regulator, Swissmedic, approved Ekterly, the first on-demand oral treatment for hereditary angioedema ** HAE is a genetic disorder characterized by recurrent episodes of swelling in various parts of the body, including the limbs, face, intestinal tract, and airway caused by deficiency in a protein known as C1 inhibitor** Co has roughly $650 mln market cap** KALV shares on Weds ended down 0.7% at $12.93, but are up ~53% YTD. ** All 10 analysts covering KALV are bullish an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250924:nL6N3VB101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2570200080","title":"KalVista announces $110M convertible senior notes offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2570200080","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570200080?lang=en_us&edition=fundamental","pubTime":"2025-09-25 04:05","pubTimestamp":1758744330,"startTime":"0","endTime":"0","summary":"KalVista (KALV) Pharmaceuticals announced that it intends to offer, subject to market conditions and other factors, $110M aggregate principal amoun...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kalvista-announces-110m-convertible-senior-notes-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kalvista-announces-110m-convertible-senior-notes-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2570080862","title":"KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, With Option for Additional $15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2570080862","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570080862?lang=en_us&edition=fundamental","pubTime":"2025-09-25 04:01","pubTimestamp":1758744076,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, With Option for Additional $15 Million. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on September 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250924:nNDLc5zCHl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2570080835","title":"Kalvista Pharmaceuticals Inc - Proceeds to Fund Working Capital and Ekterly Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2570080835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570080835?lang=en_us&edition=fundamental","pubTime":"2025-09-25 04:01","pubTimestamp":1758744061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250924:nTUA7VTLFT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2570008700","title":"Kalvista Pharmaceuticals Inc - Notes Mature on October 1, 2031","url":"https://stock-news.laohu8.com/highlight/detail?id=2570008700","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570008700?lang=en_us&edition=fundamental","pubTime":"2025-09-25 04:01","pubTimestamp":1758744061,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250924:nTUA7VTLFT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2570007087","title":"Kalvista Pharmaceuticals Announces Proposed Offering of $110.0 Million of Convertible Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2570007087","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570007087?lang=en_us&edition=fundamental","pubTime":"2025-09-25 04:01","pubTimestamp":1758744061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250924:nTUA7VTLFT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2568657912","title":"Sector Update: Health Care Stocks Rise Pre-Bell Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2568657912","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568657912?lang=en_us&edition=fundamental","pubTime":"2025-09-19 21:16","pubTimestamp":1758287777,"startTime":"0","endTime":"0","summary":"Health care stocks were rising pre-bell Friday, with the Health Care Select Sector SPDR Fund (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) 0.2% higher.ARS Pharmaceuticals (SPRY) shares were up","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","NUVB","XLV","XBI","BK4585","IBB","KALV","BK4139","SPRY","BK4581","BK4007","LABU"],"gpt_icon":0},{"id":"2568260250","title":"KalVista Gets European Commission, Swissmedic Approvals for Ekterly to Treat Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2568260250","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568260250?lang=en_us&edition=fundamental","pubTime":"2025-09-19 19:57","pubTimestamp":1758283049,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals  said Friday that the European Commission and the Swiss Agency for Therapeutic Products, Swissmedic, have approved Ekterly for the treatment of hereditary angioedema in adults and adolescents aged 12 years and older.The marketing authorizations are based on results from a phase 3 trial which showed that Ekterly achieved significantly faster symptom relief, reduction in attack severity and attack resolution than placebo, the company said.KalVista expects to initiate its first European launch in Germany in Q4 and launch in Switzerland in the second half of 2026.KalVista  shares were up by nearly 1% in premarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KALV","BK4139"],"gpt_icon":1},{"id":"2568578792","title":"Kalvista Pharmaceuticals Inc - First European Launch of Ekterly Expected in Germany Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2568578792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568578792?lang=en_us&edition=fundamental","pubTime":"2025-09-19 19:00","pubTimestamp":1758279601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250919:nTUA1GSNFK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALV","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":100,"code":"91000000","status":"200"}]}}